Related Experiment Video

Updated: Apr 5, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.8K

Lipid parameters in patients with acute coronary syndromes versus stable coronary artery disease

Alexander Vonbank1,2,3, Christoph H Saely1,2,3, Philipp Rein1,2,3

  • 1Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.

European Journal of Clinical Investigation
|August 11, 2015
PubMed

Insights

Patients with acute coronary syndromes (ACS) have lower levels of HDL cholesterol and apolipoprotein A1 compared to those with stable coronary artery disease (CAD). These findings highlight key lipid differences in cardiovascular disease states.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Lipidology
  • Interventional Cardiology

Background:

  • Lipid parameter differences between acute coronary syndromes (ACS) and stable coronary artery disease (CAD) remain unclear.
  • Understanding these differences is crucial for risk stratification and treatment strategies.

Purpose of the Study:

  • To investigate and compare lipid profiles in patients with ACS versus stable CAD.
  • To identify specific lipid markers that differ significantly between these two patient groups.

Main Methods:

  • Enrolled 582 patients with stable CAD and 182 patients with ACS.
  • Collected demographic, clinical, and lipid data, including diabetes mellitus type 2 (T2DM) status.
  • Utilized analysis of covariance (ANCOVA) to adjust for confounding factors.

Main Results:

  • Patients with ACS showed significantly lower HDL cholesterol and apolipoprotein A1 levels compared to stable CAD patients (P < 0.001).
  • ANCOVA confirmed ACS as an independent predictor of lower HDL cholesterol and apolipoprotein A1.
  • No significant differences were observed in total cholesterol, LDL cholesterol, non-HDL cholesterol, or apolipoprotein B levels.

Conclusions:

  • HDL cholesterol and apolipoprotein A1 are significantly lower in patients experiencing ACS compared to those with stable CAD.
  • These lipid markers may serve as indicators differentiating ACS from stable CAD.
Abstract

Keywords:
Acute coronary syndromeHDL cholesterolapolipoproteincoronary artery diseaselipid parameterstype 2 diabetes

More Related Videos

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.9K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
763
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
854
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
859
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
428